The success of Sildenafil initially drove a period of growth for pharma, however recent changes present a murky scenario for investors. Off-patent competitors are reducing earnings, and persistent patent challenges add https://keithfmip487473.blog4youth.com/41701768/viagra-and-the-pharmaceutical-industry-a-precarious-investment